MRC1 and neoplasm: used immunofluorescent labeled antibodies against M1 and M2 macrophages (anti-CD86 and anti-CD206, respectively) and showed significantly higher amounts of M2 macrophages in F. nucleatum-positive tumor biopsies (27).